Advertisement

Nasopharyngeal Carcinoma with Right Abducens Palsy

  • An-Guor Wang
Chapter

Abstract

A 57-year-old female noticed diplopia for 1 month. She had a history of medically controlled hyperthyroidism. The patient’s thyroid hormone and auto-antibody levels were normal except for mildly elevated anti-thyroglobulin antibody (4.24 IU/mL). She denied other systemic vascular disorders such as diabetes, hypertension, or hyperlipidemia. Her corrected visual acuity was 6/6.7 in the right eye and 6/6 in the left. Intraocular pressures were normal. A Krimsky test showed 12 prism diopters of right esotropia. A prism cover test revealed 12 prism diopters of esotropia on primary gaze, which increased to 35 prism diopters on right gaze and decreased to 2 prism diopters on left gaze. Extraocular movements showed moderate limitation of abduction in the right eye (Fig. 30.1). Anterior segments were normal. Fundoscopic examination showed a normal fundus in both eyes (Fig. 30.2). OCT showed mildly decreased peripapillary retinal nerve fiber layer (RNFL) thickness and ganglion cell-inner plexiform layer (GC-IPL) thickness in the right eye (Fig. 30.3). MR imaging of the brain showed an increased soft tissue at the lateral recess of the right nasopharynx with an upward extension into the right skull base and right-side cavernous sinus (Fig. 30.4). Nasopharyngoscopy showed a protruding mass with hypervascularity over the right nasopharynx with extension to the right posterior choana region. Nasopharyngeal carcinoma was suspected, but the patient hesitated to undergo a biopsy, and there was subsequent loss to follow-up.

References

  1. 1.
    Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet. 2005;365(9476):2041–54.CrossRefPubMedGoogle Scholar
  2. 2.
    Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, editors. Cancer incidence in five continents (IARC scientific publication no. 143), vol. 7. Lyon: IARC; 1997. p. 814–5.Google Scholar
  3. 3.
    Huang DP. Epidemiology of nasopharyngeal carcinoma. Ear Nose Throat J. 1990;69(4):222–5.PubMedGoogle Scholar
  4. 4.
    Agulnik M, Epstein JB. Nasopharyngeal carcinoma: current management, future directions and dental implications. Oral Oncol. 2008;44(7):617–27.CrossRefPubMedGoogle Scholar
  5. 5.
    Shanmugaratnam K, Sobin LH. Histological typing of tumours of the upper respiratory tract and ear. In: Shanmugaratnam K, Sobin LH, editors. International histological classification of tumours: no 19. Geneva: WHO; 1991. p. 32–3.Google Scholar
  6. 6.
    Guigay J. Advances in nasopharyngeal carcinoma. Curr Opin Oncol. 2008;20(3):264–9.CrossRefPubMedGoogle Scholar
  7. 7.
    Lu H, Peng L, Yuan X, Hao Y, Lu Z, Chen J, Cheng J, Deng S, Gu J, Pang Q, Qin J. Concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a treatment paradigm also applicable to patients in Southeast Asia. Cancer Treat Rev. 2009;35(4):345–53.CrossRefPubMedGoogle Scholar
  8. 8.
    Lu H, Yao M. The current status of intensity-modulated radiation therapy in the treatment of nasopharyngeal carcinoma. Cancer Treat Rev. 2008;34(1):27–36.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  • An-Guor Wang
    • 1
  1. 1.Department of OphthalmologyTaipei Veterans General Hospital, National Yang-Ming University School of Medicine, Yun-San Ophthalmology Education Research FoundationTaipeiTaiwan

Personalised recommendations